- Home
- SPOK vs ORIC Comparison
SPOK vs ORIC Comparison
Compare SPOK & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPOK
- ORIC
- Stock Information
- Founded
- SPOK 2004
- ORIC 2014
- Country
- SPOK United States
- ORIC United States
- Employees
- SPOK N/A
- ORIC N/A
- Industry
- SPOK Telecommunications Equipment
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- SPOK Telecommunications
- ORIC Health Care
- Exchange
- SPOK Nasdaq
- ORIC Nasdaq
- Market Cap
- SPOK 318.9M
- ORIC 362.9M
- IPO Year
- SPOK 1992
- ORIC 2020
- Fundamental
- Price
- SPOK $16.47
- ORIC $5.40
- Analyst Decision
- SPOK Hold
- ORIC Strong Buy
- Analyst Count
- SPOK 1
- ORIC 9
- Target Price
- SPOK $15.00
- ORIC $18.00
- AVG Volume (30 Days)
- SPOK 180.4K
- ORIC 650.1K
- Earning Date
- SPOK 04-30-2025
- ORIC 05-05-2025
- Dividend Yield
- SPOK 7.54%
- ORIC N/A
- EPS Growth
- SPOK N/A
- ORIC N/A
- EPS
- SPOK 0.77
- ORIC N/A
- Revenue
- SPOK $139,038,000.00
- ORIC N/A
- Revenue This Year
- SPOK $2.26
- ORIC N/A
- Revenue Next Year
- SPOK $0.14
- ORIC N/A
- P/E Ratio
- SPOK $21.51
- ORIC N/A
- Revenue Growth
- SPOK N/A
- ORIC N/A
- 52 Week Low
- SPOK $13.55
- ORIC $3.90
- 52 Week High
- SPOK $17.96
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- SPOK 59.86
- ORIC 48.72
- Support Level
- SPOK $16.41
- ORIC $4.52
- Resistance Level
- SPOK $16.69
- ORIC $5.83
- Average True Range (ATR)
- SPOK 0.58
- ORIC 0.49
- MACD
- SPOK 0.20
- ORIC 0.09
- Stochastic Oscillator
- SPOK 95.06
- ORIC 63.51
About SPOK Spok Holdings Inc.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.